BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan YZ, Chang H, Yu Y, Liu J, Zhao L, Yang DJ, Wang R. Thymopentin (TP5), an immunomodulatory peptide, suppresses proliferation and induces differentiation in HL-60 cells. Biochim Biophys Acta 2006;1763:1059-66. [PMID: 16952408 DOI: 10.1016/j.bbamcr.2006.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hou S, Wang Y, Liu N, Liu J. Preparation and Recognition Characteristics of Thymopentin Molecularly Imprinted Polymers on SiO 2. Adsorption Science & Technology 2014;32:833-43. [DOI: 10.1260/0263-6174.32.10.833] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ahmad B, Li Z, Hanif Q, Hu Q, Wei X, Zhang L, Khan SA, Aihemaiti M, Gulzar H, Shahid M, Si D, Zhang R. A Hybrid Peptide DEFB-TP5 Expressed in Methylotrophic Yeast Neutralizes LPS With Potent Anti-inflammatory Activities. Front Pharmacol 2020;11:461. [PMID: 32457599 DOI: 10.3389/fphar.2020.00461] [Reference Citation Analysis]
3 Li J, Liu CH, Wang FS. Thymosin alpha 1: biological activities, applications and genetic engineering production. Peptides. 2010;31:2151-2158. [PMID: 20699109 DOI: 10.1016/j.peptides.2010.07.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
4 Rashid K, Ahmad A. In Vitro Selective Suppression of Tumor Cells by an Oncolytic Peptide in Pancreatic Ductal Adenocarcinoma. Int J Pept Res Ther 2021;27:863-73. [DOI: 10.1007/s10989-020-10131-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Inoue E, Yotsumoto T, Inoue Y, Fukami T, Kitani M, Hirano Y, Nagase M, Morio Y. Mediastinal metastasis from ovarian serous carcinoma 29 years after initial treatment. Respir Med Case Rep 2020;29:101003. [PMID: 32257787 DOI: 10.1016/j.rmcr.2020.101003] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang Y, Yang X, Yan W, Li R, Ye Q, You L, Xie W, Mo K, Fu R, Wang Y, Chen Y, Hou H, Yang Y, Birnbaumer L, Di Q, Li X. Thymopentin improves the survival of septic mice by promoting the production of 15-deoxy-prostaglandin J2 and activating the PPARγ signaling pathway. FASEB J 2020;34:11772-85. [PMID: 32652815 DOI: 10.1096/fj.202000467R] [Reference Citation Analysis]
7 Yang B, Lu XC, Yu RL, Chi XH, Liu Y, Wang Y, Dai HR, Zhu HL, Cai LL, Han WD. Repeated transfusions of autologous cytokine-induced killer cells for treatment of haematological malignancies in elderly patients: a pilot clinical trial. Hematol Oncol 2012;30:115-22. [PMID: 22972689 DOI: 10.1002/hon.1012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zheng S, Qin T, Lu Y, Huang Y, Luo L, Liu Z, Bo R, Hu Y, Liu J, Wang D. Maturation of dendritic cells in vitro and immunological enhancement of mice in vivo by pachyman- and/or OVA-encapsulated poly(d,l-lactic acid) nanospheres. Int J Nanomedicine 2018;13:569-83. [PMID: 29416336 DOI: 10.2147/IJN.S153567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhu X, Liu J, Pan H, Geng Z, Huang W, Liu T, Zhang B. Thymopentin treatment of murine premature ovarian failure via attenuation of immune cell activity and promotion of the BMP4/Smad9 signalling pathway. Int J Med Sci 2021;18:3544-55. [PMID: 34522181 DOI: 10.7150/ijms.61975] [Reference Citation Analysis]
10 Vijayan R, Gourinath S. Structure-based inhibitor screening of natural products against NSP15 of SARS-CoV-2 revealed thymopentin and oleuropein as potent inhibitors. J Proteins Proteom 2021;:1-10. [PMID: 33776343 DOI: 10.1007/s42485-021-00059-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang Y, Cao Y, Meng Y, You Z, Liu X, Liu Z. The novel role of thymopentin in induction of maturation of bone marrow dendritic cells (BMDCs). Int Immunopharmacol 2014;21:255-60. [PMID: 24861251 DOI: 10.1016/j.intimp.2014.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
12 Wu D, Gao Y, Qi Y, Chen L, Ma Y, Li Y. Peptide-based cancer therapy: opportunity and challenge. Cancer Lett 2014;351:13-22. [PMID: 24836189 DOI: 10.1016/j.canlet.2014.05.002] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 18.0] [Reference Citation Analysis]
13 Liu T, Jing F, Huang P, Geng Z, Xu J, Li J, Chen D, Zhu Y, Wang Z, Huang W, Chen C. Thymopentin alleviates premature ovarian failure in mice by activating YY2/Lin28A and inhibiting the expression of let-7 family microRNAs. Cell Prolif 2021;54:e13089. [PMID: 34180104 DOI: 10.1111/cpr.13089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Lisitskaya KV, Nikolaev IV, Torkova AA, Popov VO, Koroleva OV. Analysis of functional properties of biologically active substances using eukaryotic cell models (review). Appl Biochem Microbiol 2012;48:525-40. [DOI: 10.1134/s0003683812060087] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Peng K, Wu C, Wei G, Jiang J, Zhang Z, Sun X. Implantable sandwich PHBHHx film for burst-free controlled delivery of thymopentin peptide. Acta Pharm Sin B 2018;8:432-9. [PMID: 29881682 DOI: 10.1016/j.apsb.2018.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Shi M, Yang Y, Zhou X, Cai L, Fang C, Wang C, Sun H, Sun Y, Gao Y, Gu J, Fawcett JP. Determination of thymopentin in beagle dog blood by liquid chromatography with tandem mass spectrometry and its application to a preclinical pharmacokinetic study: Sample Preparation. J Sep Science 2015;38:1351-7. [DOI: 10.1002/jssc.201401198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]